feed,title,long_url,short_url
news:MX,Clinical trial finds aficamten is superior to metoprolol for symptomatic obstructive hypertrophic cardiomyopathy,https://medicalxpress.com/news/2025-09-clinical-trial-aficamten-superior-metoprolol.html,
